Equity

The table provides a roll forward of equity, equity attributable to FMC stockholders, and equity attributable to noncontrolling interests.



(in Millions, Except Per Share Data)	FMC Stockholders’ Equity			Noncontrolling Interest			Total Equity
Balance at December 31, 2017	$	2,681.8		$	25.3		$	2,707.1
Net income (loss)	469.7			7.2			476.9
Stock compensation plans	26.7			—			26.7
Shares for benefit plan trust	(0.3		)	—			(0.3		)
Net pension and other benefit actuarial gains (losses) and prior service cost, net of income tax ⁽¹⁾	10.4			—			10.4
Net hedging gains (losses) and other, net of income tax ⁽¹⁾	1.1			—			1.1
Foreign currency translation adjustments ⁽¹⁾	(70.7		)	(1.3		)	(72.0		)
Dividends ($0.495 per share)	(66.9		)	—			(66.9		)
Repurchases of common stock	(5.4		)	—			(5.4		)
Noncontrolling interests associated with an acquisition	—			0.7			0.7
Balance at September 30, 2018	$	3,046.4		$	31.9		$	3,078.3

____________________


(1)	See condensed consolidated statements of comprehensive income (loss).

Accumulated other comprehensive income (loss)

Summarized below is the roll forward of accumulated other comprehensive income (loss), net of tax.



(in Millions)	Foreign currency adjustments			Derivative Instruments ⁽¹⁾			Pension and other postretirement benefits ⁽²⁾			Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2017	$	(6.2	)	$	5.2		$	(239.3	)	$	(240.3	)
2018 Activity
Other comprehensive income (loss) before reclassifications	(70.7		)	12.0			—			(58.7		)
Amounts reclassified from accumulated other comprehensive income (loss)	—			(10.9		)	10.4			(0.5		)
Accumulated other comprehensive income (loss), net of tax at September 30, 2018	$	(76.9	)	$	6.3		$	(228.9	)	$	(299.5	)



(in Millions)	Foreign currency adjustments			Derivative Instruments ⁽¹⁾			Pension and other postretirement benefits ⁽²⁾			Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2016	$	(194.0	)	$	7.1		$	(291.5	)	$	(478.4	)
2017 Activity
Other comprehensive income (loss) before reclassifications	162.4			(3.2		)	1.3			160.5
Amounts reclassified from accumulated other comprehensive income (loss)	17.0			1.3			11.0			29.3
Accumulated other comprehensive income (loss), net of tax at September 30, 2017	$	(14.6	)	$	5.2		$	(279.2	)	$	(288.6	)

____________________

(1) See Note 17 for more information.

(2) See Note 15 for more information.

Reclassifications of accumulated other comprehensive income (loss)

The table below provides details about the reclassifications from accumulated other comprehensive income (loss) and the affected line items in the condensed consolidated statements of income (loss) for each of the periods presented.



Details about Accumulated Other Comprehensive Income Components	Amounts Reclassified from Accumulated Other Comprehensive Income (Loss)⁽¹⁾												Affected Line Item in the Condensed Consolidated Statements of Income (Loss)
	Three Months Ended September 30,						Nine Months Ended September 30,
(in Millions)	2018			2017			2018			2017
Foreign currency adjustments:
Divestiture of Omega-3 business ⁽²⁾	$	—		$	(17.0	)	$	—		$	(17.0	)	Discontinued operations, net of income taxes
Derivative instruments
Foreign currency contracts	$	18.0		$	(4.9	)	$	20.4		$	(9.4	)	Costs of sales and services
Energy contracts	—			(0.2		)	—			0.6			Costs of sales and services
Foreign currency contracts	(4.0		)	2.6			(4.3		)	6.6			Selling, general and administrative expenses
Other contracts	(0.2		)	—			(0.2		)	—			Interest expense, net
Total before tax	$	13.8		$	(2.5	)	$	15.9		$	(2.2	)
	(4.6		)	1.0			(5.0		)	0.9			Provision for income taxes
Amount included in net income (loss)	$	9.2		$	(1.5	)	$	10.9		$	(1.3	)

Pension and other postretirement benefits ⁽³⁾
Amortization of prior service costs	$	—		$	(0.1	)	$	(0.2	)	$	(0.4	)	Selling, general and administrative expenses
Amortization of unrecognized net actuarial and other gains (losses)	(4.4		)	(3.6		)	(11.5		)	(10.4		)	Selling, general and administrative expenses
Recognized loss due to curtailment and settlement	(0.1		)	(1.2		)	(1.4		)	(5.9		)	Selling, general and administrative expenses; Discontinued operations, net of income taxes⁽⁴⁾
Total before tax	$	(4.5	)	$	(4.9	)	$	(13.1	)	$	(16.7	)
	0.9			1.7			2.7			5.7			Provision for income taxes
Amount included in net income (loss)	$	(3.6	)	$	(3.2	)	$	(10.4	)	$	(11.0	)
Total reclassifications for the period	$	5.6		$	(4.7	)	$	0.5		$	(12.3	)	Amount included in net income

____________________


(1)	Amounts in parentheses indicate charges to the condensed consolidated statements of income (loss).

(2)

The reclassification of historical cumulative translation adjustments was the result of the sale of our Omega-3 business. The loss recognized from this reclassification is considered permanent for tax purposes and therefore no tax has been provided. See Note 11 within these condensed consolidated financial statements for more information. In accordance with accounting guidance, this amount was previously factored into the lower of cost or fair value test associated with the Omega-3 asset held for sale write-down charges.


(3)	Pension and other postretirement benefits amounts include the impact from both continuing and discontinued operations. For detail on the continuing operations components of pension and other postretirement benefits, see Note 15.


(4)	The loss due to curtailment for the nine months ended September 30, 2017 related to the disposal of FMC Health and Nutrition was recorded to "Discontinued operations, net of income taxes" on the condensed consolidated statements of income (loss).

Dividends and Share Repurchases

For the nine months ended September 30, 2018 and 2017, we paid dividends of $66.9 million and $66.6 million, respectively. On October 18, 2018, we paid dividends totaling $22.3 million to our shareholders of record as of September 28, 2018. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of September 30, 2018.

During the nine months ended September 30, 2018, no shares were repurchased under the publicly announced repurchase program. At September 30, 2018, $238.8 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.